Prestige Consumer Healthcare
PBH · NYSE
$49.36−$0.35 (−0.70%)TodayMarket closed ·
Prev close $49.71
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 5.7% on average
Next report: , before the market opens
- Quarter
- Q2 FY27
- EPS estimate
- $1.07
- Revenue estimate
- $329.05M
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | $0.8908 | $0.98 | +10.0% |
| Q1 FY27 | $0.8908 | $0.98 | +10.0% |
| Q1 FY26 | $1.40 | $1.23 | −12.4% |
| Q4 FY25 | $1.31 | $1.32 | +0.6% |
| Q3 FY25 | $1.17 | $1.22 | +4.3% |
| Q2 FY25 | $1.10 | $1.09 | −0.5% |
| Q1 FY25 | $0.8691 | $0.90 | +3.6% |
| Q4 FY24 | $1.15 | $0.98 | −14.9% |
Earnings calls
- Barclays 19th Annual Global Consumer Staples Conference
- PBH - Earnings call Q1 2027
- PBH - Earnings call Q4 2026
- Prestige Consumer Healthcare Inc., Breathe Right - M&A Call
- PBH - Earnings call Q3 2026
- PBH - Earnings call Q2 2026
- Barclays 18th Annual Global Consumer Staples Conference 2025
- PBH - Earnings call Q1 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.